https://www.truescoopnews.com/astrazeneca-vaccine

Find whatever's trending in Punjab, India and the world on True Scoop News. From Breaking news to analysis of the trending topics, True Scoop covers it all

astrazeneca-vaccine

Chairman of India's Covid-19 Working Group of NTAGI, N.K. Arora explains how vaccine efficacy varies between 65 per cent to 88 per cent when interval is 12 weeks.

Explained: The science behind increasing gap between Covishield doses

Johnson & Johnson, last week, has said that a single batch of the ‘drug product’ has failed quality control inspection and has been discarded.

US will have enough vaccine to inoculate all adult Americans by May end: White House

"Safety is of paramount importance and the Company is continually monitoring the safety of its vaccine," the company said in a statement on Sunday.

No evidence of high blood clot risk from AstraZeneca Covid-19 vaccine, company confirms safety

The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval.

News

Explained: The science behind increasing gap between Covishield doses

US will have enough vaccine to inoculate all adult Americans by May end: White House

No evidence of high blood clot risk from AstraZeneca Covid-19 vaccine, company confirms safety

Oxford-AstraZeneca's covid-19 vaccine ‘Covishield’ cleared by expert panel